Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Medicine in Diabetes Using a Nanotechnology Platform

NCT01268813 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT01268813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01268813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Medicine in Diabetes Using a Nanotechnology Platform
Lead sponsor
Rambam Health Care Campus
Phase
Phase 1
Overall status
Unknown status
Start date
February 28, 2011
Completion date
March 31, 2013
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, metabolic syndrome